by monkey_monkey on 8/29/24, 9:44 AM with 42 comments
by hi-v-rocknroll on 8/29/24, 11:08 AM
- SGLT-2 inhibitors: canagliflozin, dapagliflozin, sotagliflozin, bexagliflozin
- DPP-4 inhibitors: sitagliptin, saxagliptin, linagliptin
Other beneficial drugs beyond/with/for diabetes and/or weight:
- Metformin
- AGIs: acarbose
- GLP-1 agonists: tirzepatide, semaglutide, liraglutide
- DACRAs: cagrilintide
Maybe in the future it will be possible to manage a person's glucose and related hormone levels in roughly a continuous keto or borderline low blood sugar state using the equivalent of an "insulin pump" and a real-time blood glucose monitor control system such that it doesn't promote low-blood sugar neurological symptoms.
by chiefalchemist on 8/29/24, 9:59 AM
by tsoukase on 8/29/24, 12:34 PM
by rawicki on 8/29/24, 11:48 AM
For some reason GLP-1 drugs are not that popular in Korea (and still not prescribed just for the weight loss), so that may explain why these researchers haven't done that.
by mgarfias on 8/29/24, 4:03 PM
by zug_zug on 8/29/24, 12:46 PM